drugset / Trial / NCT01885819

Autologous Adipose Tissue Stromal Vascular Fraction Cells for Rheumatoid Arthritis

NCT01885819 ↗

Phase 1/2 Withdrawn Translational Biosciences
NaSingle-groupOpen-labelTreatment

Summary

Autologous stromal vascular fraction (SVF) injected at 8 and 10 days after extraction is safe and useful procedure in inducing remission of RA in patients resistant to standard DMARD therapy.

Timeline

Start
2013-06
Primary completion
2016-07
Completion
2016-12

Outcome

Outcome not reported

Stopped (Business): “per sponsor decision”

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous stromal vascular fraction cells Cell therapy — —

Indications